https://assets.capyfin.com/instruments/678fdc13234e27009c5d64bd.png avatar
Outlook Therapeutics
🇺🇸 NASDAQ:OTLK
•
Sep 30, 2024

Outlook Therapeutics Q4 2024 Earnings Report

EPS
-$0.94
Previous year: -$1
-6.0%
Gross Profit
$0
0
Cash and Equivalents
$14.9M
Previous year: $23.4M
-36.2%
Free Cash Flow
-$17M
Total Assets
$28.8M
Previous year: $32.3M
-10.8%

Outlook Therapeutics Revenue

Outlook Therapeutics EPS